Dr. Lawrence Eichenfield Unpacks New Phase 3 Data on Roflumilast Cream 0.05% in AD in Kids Aged 2 to 5
Late-breaking data showing that roflumilast cream 0.05% improved atopic dermatitis (AD) symptoms in kids between the ages of 2 to 5 as early as 24 hours following the first application, made a big splash at the recent American Academy of Dermatology meeting in San Diego, CA. Arcutis’ roflumilast cream 0.3% is U.S. Food and Drug […]